Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma
Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin’s and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or neg...
Saved in:
| Published in | Bone marrow transplantation (Basingstoke) Vol. 48; no. 9; pp. 1212 - 1217 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.09.2013
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin’s and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(−) and 12 were PET/CT(+). PET/CT(+) patients were younger (
P
=0.04), had lower MCL International Prognostic Index (MIPI,
P
=0.04) scores, but increased bulky adenopathy >5 cm (45% vs 13%,
P
=0.09). With a median follow-up of 27 months (range: 5–55 months), 7 patients relapsed (4 in the PET/CT(−) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30–0.85) vs 87% (95% CI: 0.57–0.97) in PET/CT(+) and PET/CT(−) patients, respectively (
P
=0.054). OS was significantly decreased in PET/CT(+) patients (
P
=0.007), with 2-year estimates of 60% (95% CI: 0.23–0.84) vs 100% in PET/CT(−) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. |
|---|---|
| AbstractList | Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin's and diffuse large B-cell lymphoma. We classified pre- transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(-) and 12 were PET/CT(+). PET/CT(+) patients were younger (P = 0.04), had lower MCL International Prognostic Index (MIPI, P = 0.04) scores, but increased bulky adenopathy >5cm (45% vs 13%, P = 0.09). With a median follow-up of 27 months (range: 5-55 months), 7 patients relapsed (4 in the PET/CT(-) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30-0.85) vs 87% (95% CI: 0.57-0.97) in PET/CT(+) and PET/CT(-) patients, respectively (P = 0.054). OS was significantly decreased in PET/CT(+) patients (P = 0.007), with 2-year estimates of 60% (95% CI: 0.23-0.84) vs 100% in PET/CT(-) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. Bone Marrow Transplantation (2013) 48, 1212-1217;doi: 10.1038/bmt.2013.46; published online 15 April 2013 Keywords: autologous transplantation;mantle cell lymphoma;non-Hodgkin's lymphoma;PET and CT;SCT Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin's and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(-) and 12 were PET/CT(+). PET/CT(+) patients were younger (P=0.04), had lower MCL International Prognostic Index (MIPI, P=0.04) scores, but increased bulky adenopathy >5 cm (45% vs 13%, P=0.09). With a median follow-up of 27 months (range: 5-55 months), 7 patients relapsed (4 in the PET/CT(-) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30-0.85) vs 87% (95% CI: 0.57-0.97) in PET/CT(+) and PET/CT(-) patients, respectively (P=0.054). OS was significantly decreased in PET/CT(+) patients (P=0.007), with 2-year estimates of 60% (95% CI: 0.23-0.84) vs 100% in PET/CT(-) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin's and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(-) and 12 were PET/CT(+). PET/CT(+) patients were younger (P=0.04), had lower MCL International Prognostic Index (MIPI, P=0.04) scores, but increased bulky adenopathy >5cm (45% vs 13%, P=0.09). With a median follow-up of 27 months (range: 5-55 months), 7 patients relapsed (4 in the PET/CT(-) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30-0.85) vs 87% (95% CI: 0.57-0.97) in PET/CT(+) and PET/CT(-) patients, respectively (P=0.054). OS was significantly decreased in PET/CT(+) patients (P=0.007), with 2-year estimates of 60% (95% CI: 0.23-0.84) vs 100% in PET/CT(-) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin's and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(-) and 12 were PET/CT(+). PET/CT(+) patients were younger (P=0.04), had lower MCL International Prognostic Index (MIPI, P=0.04) scores, but increased bulky adenopathy >5 cm (45% vs 13%, P=0.09). With a median follow-up of 27 months (range: 5-55 months), 7 patients relapsed (4 in the PET/CT(-) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30-0.85) vs 87% (95% CI: 0.57-0.97) in PET/CT(+) and PET/CT(-) patients, respectively (P=0.054). OS was significantly decreased in PET/CT(+) patients (P=0.007), with 2-year estimates of 60% (95% CI: 0.23-0.84) vs 100% in PET/CT(-) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin’s and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(−) and 12 were PET/CT(+). PET/CT(+) patients were younger ( P =0.04), had lower MCL International Prognostic Index (MIPI, P =0.04) scores, but increased bulky adenopathy >5 cm (45% vs 13%, P =0.09). With a median follow-up of 27 months (range: 5–55 months), 7 patients relapsed (4 in the PET/CT(−) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30–0.85) vs 87% (95% CI: 0.57–0.97) in PET/CT(+) and PET/CT(−) patients, respectively ( P =0.054). OS was significantly decreased in PET/CT(+) patients ( P =0.007), with 2-year estimates of 60% (95% CI: 0.23–0.84) vs 100% in PET/CT(−) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in patients with relapsed Hodgkin’s and diffuse large B-cell lymphoma. We classified pre-transplant PET/CT performed before auto-SCT as positive or negative to evaluate the impact of pre-transplant PET/CT in mantle cell lymphoma (MCL). In 29 patients, 17 were PET/CT(−) and 12 were PET/CT(+). PET/CT(+) patients were younger (P=0.04), had lower MCL International Prognostic Index (MIPI, P=0.04) scores, but increased bulky adenopathy >5 cm (45% vs 13%, P=0.09). With a median follow-up of 27 months (range: 5–55 months), 7 patients relapsed (4 in the PET/CT(−) group and 3 in the PET/CT(+) group) with 2 deaths in the PET/CT(+) group without a documented relapse. The estimated 2-year PFS was 64% (95% confidence interval (CI): 0.30–0.85) vs 87% (95% CI: 0.57–0.97) in PET/CT(+) and PET/CT(−) patients, respectively (P=0.054). OS was significantly decreased in PET/CT(+) patients (P=0.007), with 2-year estimates of 60% (95% CI: 0.23–0.84) vs 100% in PET/CT(−) patients. A positive pre-transplant PET/CT is associated with a poor prognosis in patients with MCL. Additional factors may impact the prognostic value of PET/CT, as several PET/CT(+) patients remain in remission. |
| Audience | Academic |
| Author | Christian, B A Devine, S M Andritsos, L A Flynn, J Blum, K A Penza, S Porcu, P Benson, D M Ruppert, A S Cohen, J B Jones, J A Baiocchi, R Hall, N C |
| Author_xml | – sequence: 1 givenname: J B surname: Cohen fullname: Cohen, J B email: jonathon.cohen@osumc.edu organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 2 givenname: N C surname: Hall fullname: Hall, N C organization: Department of Radiology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 3 givenname: A S surname: Ruppert fullname: Ruppert, A S organization: Division of Biostatistics, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 4 givenname: J A surname: Jones fullname: Jones, J A organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 5 givenname: P surname: Porcu fullname: Porcu, P organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 6 givenname: R surname: Baiocchi fullname: Baiocchi, R organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 7 givenname: B A surname: Christian fullname: Christian, B A organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 8 givenname: S surname: Penza fullname: Penza, S organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 9 givenname: D M surname: Benson fullname: Benson, D M organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 10 givenname: J surname: Flynn fullname: Flynn, J organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 11 givenname: L A surname: Andritsos fullname: Andritsos, L A organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 12 givenname: S M surname: Devine fullname: Devine, S M organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University – sequence: 13 givenname: K A surname: Blum fullname: Blum, K A organization: Division of Hematology, The Arthur G James Comprehensive Cancer Center and the Wexner Medical Center at The Ohio State University |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27702195$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23584442$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNktuL1DAUh4OsuLOrT75LQRRBO5t7m8dh8QYLvuhzSNN0pkub1CRlmf_eU2Z0Z2URyUPCOV_O9XeBznzwDqGXBK8JZvVVM-Y1xYStuXyCVoRXshRMijO0wlTWJWNSnaOLlG4xJpxj8QydUyZqzjldobtNSsH2JvfBF6ErpujKHI1P02B8PpinkPoc4eHGPqXFksMYttFMu_2VDeM0Z9ee2Arj2yLMGVyu6H0xQqTBFdYNQzHsx2kXRvMcPe3MkNyL432Jfnz6-P36S3nz7fPX681NaQVnuawahZlSTLSGtFaKtjEUVxg72lV124CbEiFVZS1piO1aQiQTzhmHG0klN-wSvTvEnWL4ObuUNfSwVGK8C3PShDNFGeey-h8UaqkprgF9_Rd6G-booRENWSmpCKHqXxThVMlKUU7uqa0ZnO59F2D-dkmtN4wLSaBfBtT6EQpOC0uxIIiuB_uDD29PPuycGfIuhWFeNpoegu8PoI0hpeg6PcV-NHGvCdaLwDQITC8C01wC_erY09yMrv3D_lYUAG-OgEnWDB1oyfbpnqsqTIkSwH04cAlcfuviyXAeyfsLW5bnJQ |
| CODEN | BMTRE9 |
| CitedBy_id | crossref_primary_10_1007_s11912_018_0728_4 crossref_primary_10_2217_ijh_13_67 crossref_primary_10_1016_j_clml_2013_10_007 crossref_primary_10_3390_cancers13112558 crossref_primary_10_1186_s12885_021_08225_5 crossref_primary_10_1016_j_mednuc_2018_12_016 crossref_primary_10_21320_2500_2139_2016_9_4_406_412 crossref_primary_10_3109_10428194_2014_882506 crossref_primary_10_1093_jnci_djw263 crossref_primary_10_2967_jnumed_116_184242 crossref_primary_10_1007_s12149_019_01354_9 crossref_primary_10_1016_j_critrevonc_2020_103038 crossref_primary_10_1016_j_remn_2017_03_004 crossref_primary_10_1038_leu_2014_171 crossref_primary_10_1158_1078_0432_CCR_15_0488 crossref_primary_10_1016_j_bbmt_2014_02_009 crossref_primary_10_1517_21678707_2013_854700 crossref_primary_10_1016_j_clml_2020_01_018 crossref_primary_10_1016_j_bbmt_2015_08_035 crossref_primary_10_3390_cancers11121831 crossref_primary_10_1016_j_clml_2019_04_016 crossref_primary_10_1111_ejh_12442 crossref_primary_10_1097_MNM_0000000000001170 crossref_primary_10_1182_blood_2013_12_541953 crossref_primary_10_1016_j_remnie_2017_06_007 crossref_primary_10_2217_fon_15_92 |
| Cites_doi | 10.1200/JCO.2010.33.7055 10.1182/blood-2009-02-179739 10.1200/JCO.2011.35.0736 10.1080/10428190802216707 10.1080/10428190802419640 10.1200/JCO.2006.08.2305 10.1182/blood-2007-06-095331 10.1158/0008-5472.CAN-09-3419 10.1182/blood-2004-10-3883 10.3324/haematol.2011.050203 10.3324/haematol.2011.056051 10.1002/cncr.26731 10.1200/JCO.2006.09.2403 10.1200/JCO.2005.08.133 10.1182/blood-2009-08-236570 10.1182/blood-2011-11-391474 10.1182/blood-2002-12-3842 10.3109/10428194.2010.529208 10.1200/JCO.2009.22.2554 10.1111/j.1365-2141.2010.08228.x 10.1111/j.1365-2141.2010.08162.x |
| ContentType | Journal Article |
| Copyright | Macmillan Publishers Limited 2013 2014 INIST-CNRS COPYRIGHT 2013 Nature Publishing Group Copyright Nature Publishing Group Sep 2013 Macmillan Publishers Limited 2013. |
| Copyright_xml | – notice: Macmillan Publishers Limited 2013 – notice: 2014 INIST-CNRS – notice: COPYRIGHT 2013 Nature Publishing Group – notice: Copyright Nature Publishing Group Sep 2013 – notice: Macmillan Publishers Limited 2013. |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QO 7QP 7T5 7U9 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PQEST PQQKQ PQUKI 7X8 |
| DOI | 10.1038/bmt.2013.46 |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Immunology Abstracts Virology and AIDS Abstracts Health Medical collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE Biotechnology Research Abstracts ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1476-5365 |
| EndPage | 1217 |
| ExternalDocumentID | 3061948951 A345610703 10_1038_bmt_2013_46 23584442 27702195 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- -Q- .55 .XZ 0R~ 23N 2WC 36B 39C 3V. 4.4 406 53G 5GY 5RE 6J9 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWBL AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACIWK ACKTT ACMJI ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFFNX AFKRA AFRAH AFSHS AGAYW AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX EX3 F5P FDQFY FEDTE FERAY FIGPU FIZPM FRP FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HZ~ IAO IH2 IHR IHW INH INR ITC IWAJR J5H JSO JZLTJ KQ8 LGEZI LOTEE M1P M7P N9A NADUK NAO NQJWS NXXTH O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP X7M ZGI ZXP ~8M AADWK AAPBV AAYJO ABDEU ABFLS ABPTK ACBMV ACBRV ACBYP ACDSR ACIGE ACTTH ACVWB ADGIM ADMDM ADQMX ADYYL AEDAW AEFTE AGGBP AJDOV AMRJV BBAFP IQODW N95 NYICJ PQEST PQUKI W2D ZA5 AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION AAYFA ABGIJ AFNRJ AJCLW 7QO 7QP 7T5 7U9 7XB 8FD 8FE 8FH 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. LK8 M7N P64 7X8 |
| ID | FETCH-LOGICAL-c543t-7b9039935da1dc65dba20700e2f78db7b9215697cc1b1cfd11635eeae0b6264a3 |
| IEDL.DBID | BENPR |
| ISSN | 0268-3369 |
| IngestDate | Sat Oct 05 05:40:46 EDT 2024 Sat Oct 05 05:06:07 EDT 2024 Thu Oct 10 21:58:26 EDT 2024 Thu Oct 10 22:06:52 EDT 2024 Fri Feb 23 00:12:15 EST 2024 Fri Feb 02 04:26:28 EST 2024 Tue Aug 20 22:10:50 EDT 2024 Thu Sep 26 16:56:31 EDT 2024 Tue Oct 15 23:46:34 EDT 2024 Fri Nov 25 01:05:56 EST 2022 Fri Oct 11 20:45:52 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | mantle cell lymphoma non-Hodgkin’s lymphoma PET and CT autologous transplantation SCT Radionuclide study Prognosis Stem cell Hematopoietic cell Transplantation non-Hodgkin's lymphoma Surgery Lymphoproliferative syndrome Autologous hematopoietic stem cell transplantation Graft Radiodiagnosis Hematology B cell neoplasm Malignant hemopathy B-Lymphocyte Non Hodgkin lymphoma Treatment Mantle cell lymphoma Medical imagery Computerized axial tomography Positron emission tomography Cancer Emission tomography |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c543t-7b9039935da1dc65dba20700e2f78db7b9215697cc1b1cfd11635eeae0b6264a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 23584442 |
| PQID | 1429679241 |
| PQPubID | 36075 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1439234467 proquest_miscellaneous_1430398208 proquest_journals_2642171129 proquest_journals_1429679241 gale_infotracmisc_A345610703 gale_infotracacademiconefile_A345610703 gale_healthsolutions_A345610703 crossref_primary_10_1038_bmt_2013_46 pubmed_primary_23584442 pascalfrancis_primary_27702195 springer_journals_10_1038_bmt_2013_46 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-09-01 |
| PublicationDateYYYYMMDD | 2013-09-01 |
| PublicationDate_xml | – month: 09 year: 2013 text: 2013-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
| PublicationSubtitle | Official journal of the European Society for Blood and Marrow Transplantation |
| PublicationTitle | Bone marrow transplantation (Basingstoke) |
| PublicationTitleAbbrev | Bone Marrow Transplant |
| PublicationTitleAlternate | Bone Marrow Transplant |
| PublicationYear | 2013 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Geisler, Kolstad, Laurell, Räty, Jerkeman, Eriksson (CR8) 2010; 115 Kridel, Meissner, Rogic, Boyle, Telenius, Woolcock (CR11) 2012; 119 Lenz, Dreyling, Hoster, Wormann, Duhrsen, Metzner (CR2) 2005; 23 Dreyling, Lenz, Hoster, Van Hoof, Gisselbrecht, Schmits (CR3) 2005; 105 Fernandez, Salamero, Espinet, Sole, Royo, Navarro (CR10) 2010; 70 Brepoels, Stroobants, De Wever, Dierickx, Vandenberghe, Thomas (CR16) 2008; 49 Liu, Johnson, Koval, Malnassy, Sher, Damon (CR12) 2011; 97 Romaguera, Fayad, Feng, Hartig, Weaver, Rodriguez (CR5) 2010; 150 Juweid, Stroobants, Hoekstra, Mottaghy, Dietlein, Guermazi (CR18) 2007; 25 Budde, Guthrie, Till, Press, Chauncey, Pagel (CR7) 2011; 29 Hoster, Dreyling, Klapper, Gisselbrecht, van Hoof, Kluin-Nelemans (CR6) 2008; 111 Cheson, Pfistner, Juweid, Gascoyne, Specht, Horning (CR19) 2007; 25 Spaepen, Stroobants, Dupont, Vandenberghe, Maertens, Bormans (CR13) 2003; 102 Ghielmini, Zucca (CR1) 2009; 114 Trotman, Fournier, Lamy, Seymour, Sonet, Janikova (CR20) 2011; 29 Dickinson, Hoyt, Roberts, Grigg, Seymour, Prince (CR15) 2010; 150 Mato, Svoboda, Feldman, Zielonka, Agress, Panush (CR17) 2011; 118 Devillier, Coso, Castagna, Brenot Rossi, Anastasia, Chiti (CR14) 2012; 97 Hsi, Jung, Lai, Johnson, Cook, Jones (CR9) 2008; 49 Damon, Johnson, Niedzwiecki, Cheson, Hurd, Bartlett (CR4) 2009; 27 Meignan, Gallamini, Haioun, Polliack (CR21) 2010; 51 BD Cheson (BFbmt201346_CR19) 2007; 25 JE Romaguera (BFbmt201346_CR5) 2010; 150 R Devillier (BFbmt201346_CR14) 2012; 97 LE Damon (BFbmt201346_CR4) 2009; 27 CH Geisler (BFbmt201346_CR8) 2010; 115 R Kridel (BFbmt201346_CR11) 2012; 119 E Hoster (BFbmt201346_CR6) 2008; 111 K Spaepen (BFbmt201346_CR13) 2003; 102 M Dreyling (BFbmt201346_CR3) 2005; 105 G Lenz (BFbmt201346_CR2) 2005; 23 V Fernandez (BFbmt201346_CR10) 2010; 70 H Liu (BFbmt201346_CR12) 2011; 97 AR Mato (BFbmt201346_CR17) 2011; 118 M Meignan (BFbmt201346_CR21) 2010; 51 J Trotman (BFbmt201346_CR20) 2011; 29 LE Budde (BFbmt201346_CR7) 2011; 29 M Dickinson (BFbmt201346_CR15) 2010; 150 L Brepoels (BFbmt201346_CR16) 2008; 49 ME Juweid (BFbmt201346_CR18) 2007; 25 M Ghielmini (BFbmt201346_CR1) 2009; 114 ED Hsi (BFbmt201346_CR9) 2008; 49 |
| References_xml | – volume: 29 start-page: 3023 year: 2011 end-page: 3029 ident: CR7 article-title: Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation publication-title: J Clin Oncol doi: 10.1200/JCO.2010.33.7055 contributor: fullname: Pagel – volume: 114 start-page: 1469 year: 2009 end-page: 1476 ident: CR1 article-title: How I treat mantle cell lymphoma publication-title: Blood doi: 10.1182/blood-2009-02-179739 contributor: fullname: Zucca – volume: 29 start-page: 3194 year: 2011 end-page: 3200 ident: CR20 article-title: Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.0736 contributor: fullname: Janikova – volume: 49 start-page: 1693 year: 2008 end-page: 1701 ident: CR16 article-title: Positron emission tomography in mantle cell lymphoma publication-title: Leuk Lymphoma doi: 10.1080/10428190802216707 contributor: fullname: Thomas – volume: 49 start-page: 2081 year: 2008 end-page: 2090 ident: CR9 article-title: Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study publication-title: Leuk Lymphoma doi: 10.1080/10428190802419640 contributor: fullname: Jones – volume: 25 start-page: 571 year: 2007 end-page: 578 ident: CR18 article-title: Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2305 contributor: fullname: Guermazi – volume: 111 start-page: 558 year: 2008 end-page: 565 ident: CR6 article-title: A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma publication-title: Blood doi: 10.1182/blood-2007-06-095331 contributor: fullname: Kluin-Nelemans – volume: 70 start-page: 1408 year: 2010 end-page: 1418 ident: CR10 article-title: Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-3419 contributor: fullname: Navarro – volume: 105 start-page: 2677 year: 2005 end-page: 2684 ident: CR3 article-title: Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network publication-title: Blood doi: 10.1182/blood-2004-10-3883 contributor: fullname: Schmits – volume: 97 start-page: 579 year: 2011 end-page: 585 ident: CR12 article-title: Detection of minimal residual disease following inductionimmunochemotherapy predicts progression free survival inmantle cell lymphoma: final results of CALGB 59909 publication-title: Haematologica doi: 10.3324/haematol.2011.050203 contributor: fullname: Damon – volume: 97 start-page: 1073 year: 2012 end-page: 1079 ident: CR14 article-title: Positron emission tomography response at time of autologous stem cell transplantation predict outcome of patients with relapsed and/or refractory Hodgkin lymphoma responding to prior salvage therapy publication-title: Haematologica doi: 10.3324/haematol.2011.056051 contributor: fullname: Chiti – volume: 118 start-page: 3565 year: 2011 end-page: 3570 ident: CR17 article-title: Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD publication-title: Cancer doi: 10.1002/cncr.26731 contributor: fullname: Panush – volume: 150 start-page: 39 year: 2010 end-page: 45 ident: CR15 article-title: Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy publication-title: Br J Haematol contributor: fullname: Prince – volume: 25 start-page: 579 year: 2007 end-page: 586 ident: CR19 article-title: Revised response criteria for malignant lymphoma publication-title: J Clin Oncol doi: 10.1200/JCO.2006.09.2403 contributor: fullname: Horning – volume: 150 start-page: 200 year: 2010 end-page: 208 ident: CR5 article-title: Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma publication-title: Br J Haematol contributor: fullname: Rodriguez – volume: 23 start-page: 1984 year: 2005 end-page: 1992 ident: CR2 article-title: Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG) publication-title: J Clin Oncol doi: 10.1200/JCO.2005.08.133 contributor: fullname: Metzner – volume: 115 start-page: 1530 year: 2010 end-page: 1533 ident: CR8 article-title: The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT) publication-title: Blood doi: 10.1182/blood-2009-08-236570 contributor: fullname: Eriksson – volume: 119 start-page: 1963 year: 2012 end-page: 1971 ident: CR11 article-title: Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma publication-title: Blood doi: 10.1182/blood-2011-11-391474 contributor: fullname: Woolcock – volume: 102 start-page: 53 year: 2003 end-page: 59 ident: CR13 article-title: Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation publication-title: Blood doi: 10.1182/blood-2002-12-3842 contributor: fullname: Bormans – volume: 51 start-page: 2171 year: 2010 end-page: 2180 ident: CR21 article-title: Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8 9 April 2010 publication-title: Leuk Lymphoma doi: 10.3109/10428194.2010.529208 contributor: fullname: Polliack – volume: 27 start-page: 6101 year: 2009 end-page: 6108 ident: CR4 article-title: Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.22.2554 contributor: fullname: Bartlett – volume: 70 start-page: 1408 year: 2010 ident: BFbmt201346_CR10 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-3419 contributor: fullname: V Fernandez – volume: 25 start-page: 579 year: 2007 ident: BFbmt201346_CR19 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.09.2403 contributor: fullname: BD Cheson – volume: 150 start-page: 200 year: 2010 ident: BFbmt201346_CR5 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2010.08228.x contributor: fullname: JE Romaguera – volume: 23 start-page: 1984 year: 2005 ident: BFbmt201346_CR2 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.08.133 contributor: fullname: G Lenz – volume: 119 start-page: 1963 year: 2012 ident: BFbmt201346_CR11 publication-title: Blood doi: 10.1182/blood-2011-11-391474 contributor: fullname: R Kridel – volume: 105 start-page: 2677 year: 2005 ident: BFbmt201346_CR3 publication-title: Blood doi: 10.1182/blood-2004-10-3883 contributor: fullname: M Dreyling – volume: 29 start-page: 3194 year: 2011 ident: BFbmt201346_CR20 publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.0736 contributor: fullname: J Trotman – volume: 25 start-page: 571 year: 2007 ident: BFbmt201346_CR18 publication-title: J Clin Oncol doi: 10.1200/JCO.2006.08.2305 contributor: fullname: ME Juweid – volume: 97 start-page: 1073 year: 2012 ident: BFbmt201346_CR14 publication-title: Haematologica doi: 10.3324/haematol.2011.056051 contributor: fullname: R Devillier – volume: 115 start-page: 1530 year: 2010 ident: BFbmt201346_CR8 publication-title: Blood doi: 10.1182/blood-2009-08-236570 contributor: fullname: CH Geisler – volume: 150 start-page: 39 year: 2010 ident: BFbmt201346_CR15 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2010.08162.x contributor: fullname: M Dickinson – volume: 27 start-page: 6101 year: 2009 ident: BFbmt201346_CR4 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.22.2554 contributor: fullname: LE Damon – volume: 111 start-page: 558 year: 2008 ident: BFbmt201346_CR6 publication-title: Blood doi: 10.1182/blood-2007-06-095331 contributor: fullname: E Hoster – volume: 29 start-page: 3023 year: 2011 ident: BFbmt201346_CR7 publication-title: J Clin Oncol doi: 10.1200/JCO.2010.33.7055 contributor: fullname: LE Budde – volume: 49 start-page: 2081 year: 2008 ident: BFbmt201346_CR9 publication-title: Leuk Lymphoma doi: 10.1080/10428190802419640 contributor: fullname: ED Hsi – volume: 51 start-page: 2171 year: 2010 ident: BFbmt201346_CR21 publication-title: Leuk Lymphoma doi: 10.3109/10428194.2010.529208 contributor: fullname: M Meignan – volume: 49 start-page: 1693 year: 2008 ident: BFbmt201346_CR16 publication-title: Leuk Lymphoma doi: 10.1080/10428190802216707 contributor: fullname: L Brepoels – volume: 102 start-page: 53 year: 2003 ident: BFbmt201346_CR13 publication-title: Blood doi: 10.1182/blood-2002-12-3842 contributor: fullname: K Spaepen – volume: 118 start-page: 3565 year: 2011 ident: BFbmt201346_CR17 publication-title: Cancer doi: 10.1002/cncr.26731 contributor: fullname: AR Mato – volume: 114 start-page: 1469 year: 2009 ident: BFbmt201346_CR1 publication-title: Blood doi: 10.1182/blood-2009-02-179739 contributor: fullname: M Ghielmini – volume: 97 start-page: 579 year: 2011 ident: BFbmt201346_CR12 publication-title: Haematologica doi: 10.3324/haematol.2011.050203 contributor: fullname: H Liu |
| SSID | ssj0014405 |
| Score | 2.2481897 |
| Snippet | Positron emission tomography/computed tomography (PET/CT)-positive findings before autologous SCT (auto-SCT) are associated with inferior PFS and OS in... |
| SourceID | proquest gale crossref pubmed pascalfrancis springer |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1212 |
| SubjectTerms | 631/250/1904 692/699/67/1990/291/1621 692/700/1421 692/700/1750 Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Autografts B-cell lymphoma Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Cell Biology Computed tomography Confidence intervals Diagnosis Disease-Free Survival Drug therapy Female Health aspects Hematologic and hematopoietic diseases Hematology Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphocytes B Lymphoma Lymphoma, Mantle-Cell - diagnosis Lymphoma, Mantle-Cell - diagnostic imaging Lymphoma, Mantle-Cell - surgery Male Mantle cell lymphoma Medical sciences Medicine Medicine & Public Health Middle Aged Multimodal Imaging - methods original-article PET imaging Positron emission Positron emission tomography Positron-Emission Tomography - methods Prognosis Public Health Remission Retrospective Studies Stem cell transplantation Stem Cells Tomography Tomography, X-Ray Computed - methods Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation Conditioning - methods Transplantation, Homologous Transplants & implants Treatment Outcome |
| Title | Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma |
| URI | https://link.springer.com/article/10.1038/bmt.2013.46 https://www.ncbi.nlm.nih.gov/pubmed/23584442 https://www.proquest.com/docview/1429679241 https://www.proquest.com/docview/2642171129 https://search.proquest.com/docview/1430398208 https://search.proquest.com/docview/1439234467 |
| Volume | 48 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdrC2Mwxr7nrcs06NiTF-vDUvQ0utFSBi1jrJA3oy9DIbGzxmHsv9-draQJLX0zPlk-7qTTT7o7HSFHrggGYAXPnanrXDLmcyOCz2tbMB-9MqLPrTq_UGeX8se0nKYDt2UKq1zbxN5Qh9bjGfmYY0amRnTwdfEnx6pR6F1NJTT2yAFnEt20B99OLn7-2vgRpByCGLma5EIokzL0CjEZuzmGUjLxBbHv1pqULPPjhV2ClOqhvMVd-POW77Rfkk6fkicJS9LjQfnPyIPYPCcPz5O3_AX5uyV72tYUIz66_jLzmR0yjhraB21dwwPWfcOTM9q183SN9dgPJR_C1jtqm0DbVQekSK8aOoeeZpHi-T-d_YOh0c7tS3J5evL7-1meCi3kvpSiy7UzBQKVMlgWvCqDsxxMQRF5rSfBARmAgTLae-aYrwMDEFfGaGPhYD8krXhF9pu2iW8IddGWvmbWS19L5UvnPQAk54rohYrRZORoLepqMdynUfV-cDGpQCMVaqSSKiMfUA3VkAy6mYXVsegBH5ipjHzuW-A8BNF5m9IJgA280Wqn5eFOSxCn3yGPdlS9YYtrDQDIlPD9WvdVmuBL2DFxozRsXtmd5JvRmpGPGzL-GWPamtiusAuADwYQ2OTeNoDAYcuuM_J6GHY3_AkAj1LyjHxaj8Mt_m7L9O39jL4jj3hf6gPj5w7Jfne9iu8BcHVuRPb0VI_S3PoP380s3w |
| link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbB9tgjH3XW9dq0LEnL5Ylf-hplLGSbU2fWsibkc4yDBI7axzK_vvdyUqa0NK3kFOc4-50_uk-dIwd26TWCCvS2OqmiZUQEGtZQ9yYRICDXEvfWzU5z8eX6tc0m4aA2zKUVa59onfUdQcUIx-l1JFZEDr4tvgb09Qoyq6GERoP2SMlpSI7L6abAxflLbMhxlLGUuY69OclshzZORVSCvmVkO_WGyn45WcLs0QZNcNwi7vQ563MqX8hnb5gzwOS5CeD6l-yB659xR5PQq78NbvekjzvGk71Hr2_ynxmhn6jlvuSrSv8QFPfKG7G-24eLrEewTDwod76jpu25t2qR5Ljf1o-xyfNHKfoP5_9Q8Po5uYNuzz9cfF9HIcxCzFkSvZxYXVCMCWrjaghz2prUnQEiUuboqwtkhEW5LoAEFZAUwuEcJlzxiUWT0PKyLdsr-1at8-4dSaDRhhQ0KgcMguA8MjaxIHMndMRO16LuloMt2lUPgsuywo1UpFGKpVH7IjUUA2toJs9WJ1ID_fQSUXsi19BuxBFByY0EyAbdJ_VzsqDnZUoTtghH-6oesNWWhQIf3SGv1_rvgrbe4nnpVTnBR5dxZ3kG1uN2KcNmf6ZKtpa163oEQgeNOKv8t41iL_xwF5E7N1gdjf8SYSOSqUR-7y2wy3-bsv0_f2MHrEn44vJWXX28_z3B_Y09UM_qJLugO31Vyv3EaFXbw_9_voPDHwtfw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbB2Uwxr7nrWs16NiTF8vyR_Q0yrbQfbTsYYW8GekkwSCxs8Zh7L_fnaykCS19M5FiH_eln3R3OsaOTWYVwoo8Ncr7tBACUiUtpF5nAhxUSobaqrPz6vSi-DYtpzH_aRnTKtc-MThq2wGdkY9yqsisCR2MfEyL-Pl58nHxJ6UOUhRpje007rJ7uEpm1Mahnm42XxTDLIfzlnEqZaVirV4mxyMzp6RKIT8QCt5anaKPfrDQS-SXHxpd3IREr0VRw-I0ecQeRlTJTwY1eMzuuPYJ2z-LcfOn7O-WFHjnOeV-9OFa85keao9aHtK3LvGBOsDRGRrvu3m80HoEQ_MHu_Ub163l3arHIcd_t3yOb5o5TpEAPvuHStLN9TN2Mfny69NpGlsupFAWsk9rozKCLKXVwkJVWqNzdAqZy309tgaHESJUqgYQRoC3AuFc6Zx2mcGdUaHlc7bXdq17ybhxugQvNBTgiwpKA4BQyZjMgaycUwk7XrO6WQw3azQhIi7HDUqkIYk0RZWwIxJDM5SFbuyxOZEB-qHDStj7MIMsElkHOhYWIBl0t9XOzIOdmchO2Bk-3BH1hqy8rhEKqRL_v5Z9E019iXunXFU1bmPFjcNXepuwt5th-jJlt7WuW9ErEEgoxGLjW-cgFsfNe52wF4PaXdEnEUYWRZ6wd2s93KLvOk9f3U7oEdtH02p-fD3__prdz0P_D0qqO2B7_eXKvUEU1pvDYF7_ASH0Mas |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+pre-transplantation+positron+emission+tomography%2Fcomputed+tomography+and+outcome+in+mantle+cell+lymphoma&rft.jtitle=Bone+marrow+transplantation+%28Basingstoke%29&rft.au=Cohen%2C+J.B&rft.au=Hall%2C+N.C&rft.au=Ruppert%2C+A.S&rft.au=Jones%2C+J.A&rft.date=2013-09-01&rft.pub=Nature+Publishing+Group&rft.issn=0268-3369&rft.eissn=1476-5365&rft.volume=48&rft.issue=9&rft.spage=1212&rft_id=info:doi/10.1038%2Fbmt.2013.46&rft.externalDocID=A345610703 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-3369&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-3369&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-3369&client=summon |